Demographic and visual outcomes on keratoconus patients with failed - PowerPoint PPT Presentation

About This Presentation
Title:

Demographic and visual outcomes on keratoconus patients with failed

Description:

Demographic and visual outcomes on keratoconus patients with failed epi- on C3R cross-linking procedures Yaron S. Rabinowitz M.D. Oana Dumitrascu M.D. – PowerPoint PPT presentation

Number of Views:39
Avg rating:3.0/5.0
Slides: 12
Provided by: yaronrab
Category:

less

Transcript and Presenter's Notes

Title: Demographic and visual outcomes on keratoconus patients with failed


1
Demographic and visual outcomes on keratoconus
patients with failed epi- onC3R cross-linking
procedures
  • Yaron S. Rabinowitz M.D.
  • Oana Dumitrascu M.D.
  • The authors have no financial interest in the
    materials presented in this poster

2
Background
  • The standard procedure in collagen
    cross-linking is to remove the epithelium. Recent
    reports suggest that it is not necessary to
    remove the epithelium using the epi-on C3R
    procedure. This study was undertaken to
    illustrate C3R failures.

3
Abstract
  • PURPOSE To present data on unhappy keratoconus
    patients
  • who presented to our office following C3R
    epi-on cross-linking.
  • METHODS Retrospective chart review 1 year post
    procedure
  • RESULTS 13 eyes were identified. Mean age was 33
    yrs
  • (range 23 41). Mean uncorrected acuity was
    20/200
  • (range 20/40-20/200). Mean best-corrected acuity
    was 20/60
  • (range 20/30-20/200). Mean central pachymetry
    was 435um
  • (range 380-485). Mean K value was 50.27(range
    43-58).
  • Mean I-S value was 4.25(range 1.84-10.86). 4 eyes
    had
  • repeat cross-linking with the standard epi-off
    procedure, 4 eyes
  • had corneal transplants and 5 eyes had no
    further treatment
  • CONCLUSIONS These data suggest that the epi-on
    C3R
  • procedure may not be optimal for treating
    keratoconus.

4
Results - Demographics of failed epi-on
N Age Reason for consult UCVA BSCVA Ks Pach Additional findings/surgery
1 14 Progressed 7D in 1 year 20/400 20/80 57/53 417 Clear cornea
2 14 Progressed 8D in 1 year 20/400 20/70 58/52 444 Intacs
3 26 Progressed by 3D CF 2 ft 20/400 54/48 446 Paracentral scar
4 28 No visual improvement 20/150 20/30 51/49 409 Intacs and ICL
5 28 No visual improvement 20/80 20/40 46/42 473 Intacs and ICL
6 32 No improvement in VA 20/40 20/25 45/42 479 Intacs and 2nd C3R
7 32 No improvement in VA 20/80 20/40 50/51 454 Intacs and 2nd C3R
8 33 Rapid progression CF 20/400 54/41 381 Intacs
9 36 Progression worse VA 20/40 20/40 56/45 418 Intacs, CK and ICL
10 36 Progression worse VA 20/70 20/40 57/48 435 Intacs, CK and ICL
11 42 Progression worse VA 20/400 20/70 53/48 380 Paracentral scar
12 42 Progression worse VA 20/150 20/70 50/47 461 Paracentral scar
13 51 No improvement in VA CF 1ft CF 1ft 63/56 381 Paracentral scar/Epi Lasik
5
Results - DemographicsSummary of findings at
presentation
  • 4/13 (30) eyes had paracentral scars
  • 9/13 (70) eyes had 1 additional surgery
  • 6/13 (46) eyes had 2 additional surgeries
  • 3/13 (23) eyes had 3 additional surgeries

6
Results - reasons why patients not happy
  • 8/13(60) patients noted progression after C3R,
    we were able to document this in 5 patients one
    progressed up to 8D
  • 5/13(40) did not experience an improvement in
    their vision which was their reason for doing the
    procedure

7
Eye 2 - Pre op and 1 year Post op topography C3R
- 8 D change
8
Results - Disposition of Failed C3R patients
N Age UCVA BSCVA Ks Pach Disposition and results
1 14 20/400 20/80 57/53 417 I.E.K./AK UCVA 20/30
2 14 20/400 20/70 58/52 444 I.E.K./LASIK UCVA 20/25
3 26 CF 2 ft 20/400 54/48 446 RGP BCVA 20/60-
4 28 20/150 20/30 51/49 409 Glasses BSCVA 20/30-
5 28 20/80 20/40 46/42 473 Glasses BSCVA 20/80-
6 32 20/40 20/25 45/42 479 Repeat CXL epi off UCVA 20/30
7 32 20/80 20/40 50/51 454 Repeat CXL epi off UCVA 20/50
8 33 CF 20/400 54/41 381 I.E.K/LASIK UCVA 20/20
9 36 20/40 20/40 56/45 418 Repeat CXL epi off UCVA 20/40
10 36 20/70 20/40 57/48 435 Repeat CXL epi off UCVA 20/70
11 42 20/400 20/70 53/48 380 RGP BCVA 20/60-
12 42 20/150 20/70 50/47 461 RGP BCVA 20/70
13 51 CF 1ft CF 1ft 63/56 381 I.E.K./AK UCVA 20/30
9
Discussion
  • Collagen Cross Linking(CXL) involves the removal
    of the corneal epithelium, soaking the cornea
    with riboflavin and applying a homogenous beam of
    UV light for about 30 minutes to the cornea.
  • Several studies in the published literature
    suggest that this is a safe and effective method
    for retarding the progression of keratoconus
  • C3R is a variation of this procedure in which the
    epithelium is retained and a lamp of unknown
    origin is used for UV radiation. It is not FDA
    approved but done on an off label basis
  • This procedure is heavily marketed as being safe
    and effective, with a lt 2 retreatment rate being
    quoted
  • For C3R,there have been no scientific studies to
    date demonstrating a high safety profile as has
    been done for CXL

10
Discussion
  • In this study we demonstrate that 13 eyes from
    one practice performing C3R had an unfavorable
    outcome in a 1 year period
  • This suggests that the failure rate for C3R may
    be higher than the quoted 1.4 retreatment rate
  • 5/13 eyes were unhappy because they noticed no
    visual improvement, 4 had paracentral scars
  • 8/13 eyes noted definite progression within 1
    year of receiving the treatment
  • This suggests that patient selection for this
    particular procedure might have been less than
    optimal

11
Conclusion
  • While Collagen Cross linking (CXL) appears to be
    safe and effective as described by the pioneers
    of this procedure, it appears that performing
    this procedure leaving the epithelium on requires
    further study for safety and efficacy, before
    being universally adopted.
  • Patients expectations for improved vision should
    be tempered with the emphasis being placed on
    retarding the progression, which currently has a
    quoted 7.6 retreatment rate using the standard
    epi-off CXL procedure
Write a Comment
User Comments (0)
About PowerShow.com